Case studies of health economic analyses informing pharmaceutical health technology assessments for essential medicine selection and public-sector guidelines in South Africa
2024

Economic Analyses for Essential Medicines in South Africa

publication Evidence: moderate

Author Information

Author(s): Trudy D. Leong, Jacqui Miot, Andy Parrish, Jane Riddin, Yasmina Johnson, Tamara Kredo

Primary Institution: Health Systems Research Unit, South African Medical Research Council

Hypothesis

How do economic analyses influence the selection and access to essential medicines in South Africa?

Conclusion

A standardized health technology assessment process is essential for informed decision-making regarding essential medicines in South Africa.

Supporting Evidence

  • Economic analyses reflected methodologies described in the HTA guide.
  • Decision-making was influenced by economic analyses leading to price reductions.
  • Improved equitable access to essential medicines was achieved through these analyses.
  • Standardized HTA processes are necessary for effective decision-making.

Takeaway

This study looked at how different methods of analyzing medicine costs can help decide which medicines are available in South Africa. It found that using these methods can make medicines more affordable and accessible.

Methodology

Descriptive collective case study design analyzing four selected economic analyses.

Potential Biases

Potential bias due to reliance on secondary data and expert engagement.

Limitations

Only four case studies were reviewed, which may not represent all economic analyses conducted.

Participant Demographics

Focus on essential medicines in the South African public health sector.

Digital Object Identifier (DOI)

10.1017/S0266462324000448

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication